The treatment of research and development in corporate income tax in Hungary is one of the most complex yet value‑adding areas of tax planning and strategic decision‑making. While the legislative objective is to promote innovation and strengthen a knowledge‑based economy, the practical regulatory framework contains several critical decision points which, without conscious planning, may entail significant tax risks. R&D‑related incentives can no longer be assessed in isolation but must be evaluated comparatively.

Core logic of the research and development tax base reduction in corporate income tax

The classic corporate income tax incentive for research and development in Hungary is the tax base reduction linked to the direct costs of basic research, applied research and experimental development carried out within the company’s own scope of activities. The essence of this mechanism is that properly identified and documented R&D costs reduce the pre‑tax result and thereby the payable corporate income tax.

In practice, the definition of “direct costs” is the most critical issue. Typically, these include:

• wage costs of employees directly involved in research and development,
• materials used for R&D projects,
• depreciation of assets used in the R&D activity.

General operating, administrative or sales costs may not be classified as direct costs, even if they are indirectly related to the development activity.

This incentive may provide a stable and predictable solution for companies regularly carrying out research and development in Hungary and having a sufficient tax base. However, in the case of loss‑making or low‑profit operations, the tax benefit may be deferred over time, making it necessary to consider alternative incentive structures.

Experimental development and the impact of accounting decisions on corporate income tax

One of the most significant strategic decisions related to research and development concerns the accounting treatment of experimental development costs. The company may choose between the following accounting options:

• immediate expensing of the costs, or
• capitalisation of the costs as an intangible asset (provided that the applicable accounting conditions are met).

This decision goes beyond purely technical reporting considerations. Capitalisation affects both the tax base and the timing of incentives. The application of R&D costs as a tax base reduction may be performed either immediately or proportionally through depreciation; however, the decision is final and cannot be amended retrospectively. For multi‑year development projects, an advance review of the project’s financial lifecycle is therefore of particular importance.

Special structures in the application of research and development in corporate income tax

Group‑level R&D: between related parties

A specific feature of the R&D tax base reduction is that, subject to certain conditions, it may be transferred to a related company. This may be particularly relevant within corporate groups where the entity performing the Hungarian R&D activity is unable to fully utilise the incentive on its own. However, such a transfer creates joint and several liability between the transferor and the transferee, thereby extending the associated risks to the group level.

Collaborative R&D: joint activities with a higher education institution or research organisation

A further significant incentive applies to R&D activities carried out jointly with a higher education institution or research organisation in Hungary. In the case of genuine collaboration, the tax base may be reduced by up to three times the direct costs, up to a defined threshold. The applicability of this structure is determined primarily by the substance of the cooperation; a mere client-service provider relationship is not sufficient.

New direction: the R&D tax incentive and the obligation to choose

From 2024, the R&D tax incentive in Hungary has been introduced as a new incentive, fundamentally changing the decision logic. This instrument no longer reduces the tax base but directly decreases the payable corporate income tax. For the same R&D costs, a company may not apply both the tax base reduction and this tax incentive simultaneously, thus requiring a conscious and well‑founded choice.

One of the most attractive features of the new tax incentive is that any unused amount may, after a defined period, be refunded in cash. This option is particularly valuable for companies that do not have a significant corporate income tax liability over an extended period but carry out intensive research and development activities in Hungary.

Audit focus areas and risks

When applying R&D incentives, audit exposure cannot be ignored. During tax authority audits in Hungary, the following aspects are typically examined:

• the recognition and allocation of costs,
• the qualification of the activity as research and development,
• development objectives,
• the element of novelty,
• technological or scientific uncertainty,
• the professional background of the projects.

Deficiencies in documentation or attempts at ex post qualification may result in significant tax risks, particularly where incentives affect multiple taxes, including corporate income tax, local business tax and the innovation contribution.

The treatment of research and development in Hungarian corporate income tax is no longer about a single “good solution” but about conscious and well‑considered choices. Selecting the appropriate structure requires a combined assessment of the company’s financial position, development strategy and risk tolerance. With proper planning, R&D incentives may provide a genuine competitive advantage; misapplication, however, may create substantial long‑term risks.If you wish to avoid leaving money on the table, please contact the corporate income tax experts of WTS Klient Hungary with confidence and request a proposal.

This article is for general information purposes only and should not be considered as advice.